EN
Patient-first cell therapy innovation
 
T cell receptor repertoire as a prognosis marker for heat shock protein peptide complex-96 vaccine trial against newly diagnosed glioblastoma.
  • 0
Zhang Y., Mudgal P., Wang L., Wu H., Huang N., Alexander P.B., Gao Z., Ji N. & Li Q.-J. (2020) T cell receptor repertoire as a prognosis marker for heat shock protein peptide complex-96 vaccine trial against newly diagnosed glioblastoma. OncoImmunology, 9(1):1749476. (PMCID: PMC7153824)

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153824/



Copyright © 2019 TCR CURE Biopharma Technology Co., Ltd Powered by vancheer
About TCRCure
Research and Development
Products and Clinic
News and Media
Recruitment

Copyright © 2019 TCR CURE Biopharma Technology Co., Ltd Powered by vancheer